Interest of a standardized hypnotic message for the reduction of pain and anxiety in cancer patients treated by capsaicin patch for neuropathic pain: a randomized controlled trial.


Journal

BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232

Informations de publication

Date de publication:
27 May 2021
Historique:
received: 14 01 2021
accepted: 17 05 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 15 12 2021
Statut: epublish

Résumé

Neuropathic pain is characterized by spontaneous painful symptoms. Medical therapies include the use of a capsaicin 8% patch (Qutenza®, Grünenthal Gmbh, Germany), and patients may experience a sharp burning sensation at application and removal of the patch. This study aimed to evaluate the impact of playing a standardized hypnosis recording during application, on the pain and anxiety induced by capsaicin treatment. In a randomized, controlled trial, we assessed the benefits of the intervention firstly on pain and secondly on anxiety, as measured using numerical rating scales. All patients had application of the capsaicin patch, including the possibility for the patient to apply a cold patch. Participants were randomly assigned to one of 3 groups, namely the "Standard group" (no intervention), "Hypnosis group", in which a standardized hypnotic message was played during application, or the "Music group" in which relaxing music was played during application of the patch. Sixty-nine patients were included. Overall, there was no significant difference in pain scores between groups (p = 0.355). Compared to standard application, anxiety was significantly lower in the hypnosis group after application (p = 0.007), with no significant difference between the standard and music arms (p = 0.271), or between the hypnosis and music arms (p = 0.423). Listening to a standardized hypnotic message during application of a capsaicin patch was found to significantly lower anxiety. These findings indicate that the use of a hypnotic message can reduce discomfort and warrant its evaluation in other indications of pain or anxiety during treatment procedures. NCT02822625 .

Sections du résumé

BACKGROUND BACKGROUND
Neuropathic pain is characterized by spontaneous painful symptoms. Medical therapies include the use of a capsaicin 8% patch (Qutenza®, Grünenthal Gmbh, Germany), and patients may experience a sharp burning sensation at application and removal of the patch. This study aimed to evaluate the impact of playing a standardized hypnosis recording during application, on the pain and anxiety induced by capsaicin treatment.
METHODS METHODS
In a randomized, controlled trial, we assessed the benefits of the intervention firstly on pain and secondly on anxiety, as measured using numerical rating scales. All patients had application of the capsaicin patch, including the possibility for the patient to apply a cold patch. Participants were randomly assigned to one of 3 groups, namely the "Standard group" (no intervention), "Hypnosis group", in which a standardized hypnotic message was played during application, or the "Music group" in which relaxing music was played during application of the patch.
RESULTS RESULTS
Sixty-nine patients were included. Overall, there was no significant difference in pain scores between groups (p = 0.355). Compared to standard application, anxiety was significantly lower in the hypnosis group after application (p = 0.007), with no significant difference between the standard and music arms (p = 0.271), or between the hypnosis and music arms (p = 0.423).
CONCLUSIONS CONCLUSIONS
Listening to a standardized hypnotic message during application of a capsaicin patch was found to significantly lower anxiety. These findings indicate that the use of a hypnotic message can reduce discomfort and warrant its evaluation in other indications of pain or anxiety during treatment procedures.
TRIAL REGISTRATION BACKGROUND
NCT02822625 .

Identifiants

pubmed: 34044838
doi: 10.1186/s12906-021-03329-8
pii: 10.1186/s12906-021-03329-8
pmc: PMC8161949
doi:

Substances chimiques

Analgesics 0
Capsaicin S07O44R1ZM

Banques de données

ClinicalTrials.gov
['NCT02822625']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

154

Références

J Pain. 2010 Jun;11(6):579-87
pubmed: 20400377
Int J Clin Exp Hypn. 1979 Jan;27(1):29-41
pubmed: 541126
Expert Rev Neurother. 2011 Jan;11(1):15-27
pubmed: 21158551
Neurosci Biobehav Rev. 2019 Apr;99:298-310
pubmed: 30790634
Curr Med Res Opin. 2012 Jun;28(6):937-51
pubmed: 22551228
Burns. 2018 Feb;44(1):108-117
pubmed: 28801149
Br J Anaesth. 2011 Oct;107(4):490-502
pubmed: 21852280
Brain Res Cogn Brain Res. 2003 Jul;17(2):255-62
pubmed: 12880897
Int J Clin Exp Hypn. 2016;64(1):75-115
pubmed: 26599994
Drugs. 2018 Sep;78(14):1489-1500
pubmed: 30251173
Lancet. 2015 Oct 24;386(10004):1659-71
pubmed: 26277246
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52
pubmed: 22588748
Drug Des Devel Ther. 2017 Sep 13;11:2709-2718
pubmed: 29066862
Lancet Neurol. 2008 Dec;7(12):1106-12
pubmed: 18977178
Pain. 2007 Jul;130(1-2):137-43
pubmed: 17215080
Conscious Cogn. 2005 Jun;14(2):304-15
pubmed: 15950884
J Clin Epidemiol. 2007 Apr;60(4):356-60
pubmed: 17346609
Int J Clin Exp Hypn. 1978 Oct;26(4):307-16
pubmed: 681032

Auteurs

Rémi Etienne (R)

Department of Supportive Care in Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France.

Myriam Laurent (M)

Department of Supportive Care in Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France.

Aline Henry (A)

Department of Supportive Care in Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France.

Antoine Bioy (A)

University of Paris 8, Laboratory of Psychopathology and Neuropsychology, St Denis, Paris, France.

Julia Salleron (J)

Departement of biostatistics, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France. j.salleron@nancy.unicancer.fr.

Cécile Huin Schohn (CH)

Research Department, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France.

Nathalie Cretineau (N)

Department of Supportive Care in Oncology, Institut de Cancérologie de Lorraine, Université de Lorraine, F-54519, Vandœuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH